Esophageal Squamous Cell Cancer

13 clinical trials · Condition

Record	Firm	Date
Toripalimab with Paclitaxel and Cisplatin As Neoadjuvant Treatment for Esophageal Squamous Cell Carcinoma (NCT04804696)	Peking University	2021-02-10
Metabolomic and BH3 Profiling of Esophageal Cancers: Identification of Novel Assessment Methods of Treatment Response for Precision Therapy (NCT03223662)	National Cancer Institute (NCI)	2017-10-31
Sequential Paclitaxel Plus Cisplatin Chemotherapy and Radiotherapy as 1st Line Treatment for Esophageal Squamous Cell Cancer (NCT02016274)	Shen Lin	2013-12-01
Sequential Paclitaxel Chemotherapy and Radiotherapy as 1st Line Treatment for Elderly Esophageal Squamous Cell Cancer (NCT02016287)	Shen Lin	2013-12-01
Study of Nimotuzumab to Treat Esophageal Squamous Cell Carcinoma. (NCT01993784)	Peking University	2013-08-01
Cisplatin and 5-FU +/- Panitumumab for Patients With Nonresectable,Advanced or Metastatic Esophageal Squamous Cell Cancer (NCT01627379)	AIO-Studien-gGmbH	2012-05-01
A Study of LGK974 in Patients With Malignancies Dependent on Wnt Ligands (NCT01351103)	Novartis Pharmaceuticals	2011-12-01
Nimotuzumab Plus Paclitaxel and Cisplatin as 1st Line Treatment for Esophageal Squamous Cell Cancer (NCT01336049)	Peking University	2011-03-01

Every clearance here is in the API, with alerts when new ones post.